Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

NOAH responds to CMA issues statement
Regulations surrounding prescription medication impacts how veterinary practices can describe options.
The trade association explained how VMPs are regulated.

The National Office for Animal Health (NOAH) has published its response to the Competition and Markets Authority’s (CMA’s) issues statement.

In its letter NOAH explains how veterinary medicinal products (VMPs) are regulated, and the pricing of VMPs is decided across the industry.

Through NOAH’s Code of Practice, as well as Veterinary Medicines Regulations, companies are prohibited from promoting prescription products to the public. As such, NOAH explains that companies may be restricted in the extent they can inform pet owners of their choices, if such choices relate to prescription-only products.

NOAH describes how the animal health industry has no involvement in the pricing of veterinary medicines for the public. While the animal health industry does decide upon the prices which prescribing veterinary practices and wholesalers pay, it does not devise the prices which pet owners then pay.

The trade association explains that many owners may also not understand that prescriptions can be fulfilled in online pharmacies or other veterinary practices. It suggests that greater publicity on this matter may benefit clients.

NOAH also explains how medicine regulation and the involvement of the Veterinary Medicines Directorate (VMD) affects the medicine market.

This includes the lengthy and expensive process of developing an animal medicine, and the four classifications under which veterinary medicines can be sold.

NOAH calls the veterinary medicines sector a ‘comparatively small industry’, in that the case for producing a veterinary medicine is dependent on them being used ahead of human medicines and unauthorised products.

Dawn Howard, NOAH chief executive, said: “We appreciate the CMA’s attention to the veterinary sector and the opportunity to provide our perspective. The veterinary medicines industry and veterinarians are essential in safeguarding animal health and welfare, and it is crucial that any regulatory changes consider the unique aspects of how our sector and veterinary practices operate.

“NOAH is committed to working with the CMA to ensure that the needs of pet owners, as well as the professional and economic realities of the animal health industry and veterinary practices, are met.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
Government releases latest bluetongue statistics

APHA has confirmed the number of bluetongue cases that have been logged in the UK since 1 July 2026.

The total number of BTV-3 cases, as of 6 August, is 187. This includes 183 cases in England and four cases in Wales.

There have been no recorded cases in Scotland and Northern Ireland.

The location of premises in Great Britain where at least one animal has tested positive by PCR for BTV-3, BTV-8 or BTV-12 is available on the bluetongue case map. All livestock keepers in Great Britain are urged to familiarise themselves with nation-specific bluetongue control policies.

Bluetongue virus is a notifiable disease. It is a legal requirement that any suspicions, even if livestock has been vaccinated, are reported immediately.